Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:

‍

Nested Therapeutics, a newly public biotech company, has raised $125 million for its cancer research. Kevan Shokat, who aided the creation of a medicine that targets the cancer gene KRAS, is one of Nested's founders. (BioPharma Dive)

With hurricane season underway, and major storms impacting Puerto Rico, Florida, and elsewhere, MassDevice asks, "What’s next for the medical device supply chain?"

Motley Fool features two medical device makers that appear resistant to the current market trends—Cardinal Health, and ShockWave Medical.

The CNS Summit 2022 will be held on November 17–20, in Boca Raton, Florida. Created as "a community of innovators and industry leaders who are not afraid to challenge the status quo," CNS was founded in 2009 to advance clinical development, focused on collaboration and innovation. Team Judi will be there!

‍

‍

Our Culture

“The Judi platform is purpose-built to drive clinical trial success—cloud-based, secure, collaborative. Our greatest strength, above all else, is our people."

‍      –Abraham Gutman, President & CEO

‍‍

‍

‍

About Judi

Judi empowers and enhances the world's clinical trial ecosystems. Our cloud-based platform has 120,000 users across 168 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.